Home > Drug Search >
  • company_query: Atterocor
  •   > 
Drug Filter
Category:
chemistry (26) biology (7)
Status:
Phase Ⅲ (1) Phase Ⅱ (22) Phase Ⅰ (10)
Clinical Stage:
Pending (4) Active (27) Discontinued (2)
Bio-Type:
Vaccine (1) Recombinant cytokines (1) Whole antibody (2)
Indication:
Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (5) Anxiety (2) Breast cancer (3) Cerebral infarction (1) Depression (1) HIV infection (1) Hypercholesterolemia (1) Hypertension (1) Lymphoma (2) Major depressive disorder (MDD) (1) Malignancies (1) Multiple myeloma (MM) (1) Myeloid leukemia (1) Non small cell lung cancer (NSCLC) (2) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (1) Prostate cancer (4) Schizophrenia (1) Solid tumours (6) Hodgkin lymphoma (1) Colorectal cancer (2) Spinal cord injury (1) Autoimmune diseases (1) Acute radiation syndrome (1) Acute stroke (1) Glioblastoma (1) Esophagus cancer (1) Graft versus host disease (1) Mesothelioma (1) Stem cell mobilization (1) Cutaneous neoplasms (1) Adrenocortical carcinoma (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top